PLK1 and cancer: The clonogenic assay results for SKBR-3 cells treated with eCas12f1-PLK1 showed an 81.82% reduction in colony numbers compared to the non-targeting control (NTC), validating that eCas12f1 efficiently reduced the survival rate of cancer cells by interfering with the reproductive ability (Fig. 5c, d).